open access

Vol 52, No 3 (2018)
Case reports
Submitted: 2017-08-24
Published online: 2018-02-06
Get Citation

Intraventricular treatment of secondary central nervous system lymphoma – Case study and literature overview

Dariusz Szczepanek1, Ewa Wąsik-Szczepanek2, Agnieszka Szymczyk23, Tomasz Gromek2, Ewelina Grywalska4, Monika Podhorecka2, Marek Hus2
DOI: 10.1016/j.pjnns.2018.01.007
·
Neurol Neurochir Pol 2018;52(3):410-414.
Affiliations
  1. Chair and Department of Neurosurgery and Paediatric Neurosurgery Medical University of Lublin, Poland
  2. Chair and Department of Haematooncology and Bone Marrow Transplantation Medical University of Lublin, Poland
  3. Independent Clinical Transplantology Unit Medical University of Lublin, Poland
  4. Chair and Department of Clinical Immunology Medical University of Lublin, Poland

open access

Vol 52, No 3 (2018)
Case reports
Submitted: 2017-08-24
Published online: 2018-02-06

Abstract

Secondary nervous system lymphoma (SCNSL) is a rare extranodal form of non-Hodgkin lymphoma (NHL). This applies to a particular form of lymphoma that does not originally derive from the central nervous system (CNS); it can be both an isolated form of relapse or a systemic part of disease progression. Due to poor prognosis and a lack of established algorithms of therapeutic procedures, it is a big challenge for physicians from many specializations. In our study, we present an interesting case of a patient with a relapsed form of SCNSL for whom a unique form of treatment was used – intraventricular administration of rituximab and methotrexate.

Abstract

Secondary nervous system lymphoma (SCNSL) is a rare extranodal form of non-Hodgkin lymphoma (NHL). This applies to a particular form of lymphoma that does not originally derive from the central nervous system (CNS); it can be both an isolated form of relapse or a systemic part of disease progression. Due to poor prognosis and a lack of established algorithms of therapeutic procedures, it is a big challenge for physicians from many specializations. In our study, we present an interesting case of a patient with a relapsed form of SCNSL for whom a unique form of treatment was used – intraventricular administration of rituximab and methotrexate.

Get Citation

Keywords

Primary central nervous system lymphomas, Secondary central nervous system lymphomas, Ommaya reservoir, Intraventricular treatment

About this article
Title

Intraventricular treatment of secondary central nervous system lymphoma – Case study and literature overview

Journal

Neurologia i Neurochirurgia Polska

Issue

Vol 52, No 3 (2018)

Pages

410-414

Published online

2018-02-06

Page views

457

Article views/downloads

594

DOI

10.1016/j.pjnns.2018.01.007

Bibliographic record

Neurol Neurochir Pol 2018;52(3):410-414.

Keywords

Primary central nervous system lymphomas
Secondary central nervous system lymphomas
Ommaya reservoir
Intraventricular treatment

Authors

Dariusz Szczepanek
Ewa Wąsik-Szczepanek
Agnieszka Szymczyk
Tomasz Gromek
Ewelina Grywalska
Monika Podhorecka
Marek Hus

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl